Presentation of viral antigen controlled by a gene in the major histocompatibility complex

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Major histocompatibility complex (MHC) class I molecules are crucial for presenting intracellular antigens to cytotoxic T lymphocytes.
• Defects in MHC class I antigen presentation are associated with immune evasion strategies employed by viruses and tumor cells.
• Understanding these defects provides insights into immune surveillance and potential therapeutic targets.

Purpose of the Study:

• To characterize a novel mutant human cell line (LBL 721.174) with a defect in intracellular antigen presentation.
• To investigate the molecular mechanisms underlying the observed antigen presentation defect.
• To map the genetic locus responsible for the mutation.

Main Methods:

• Generation and characterization of the LBL 721.174 mutant cell line.
• Flow cytometry analysis to assess MHC class I surface expression.
• Peptide loading assays to evaluate antigen presentation capacity.
• Genetic mapping studies to identify the chromosomal location of the defect.

Main Results:

• The LBL 721.174 cell line exhibits impaired presentation of intracellular viral antigens via MHC class I molecules.
• The cells show a defect in the assembly and expression of MHC class I molecules.
• Exposure to exogenous peptide epitopes partially restored MHC class I expression and function.
• The genetic defect was mapped to the major histocompatibility complex (MHC) locus on human chromosome 6.

Conclusions:

• The LBL 721.174 cell line possesses a defect in the association of intracellular antigens with MHC class I molecules.
• This defect is analogous to the murine RMA-S mutant, suggesting conserved mechanisms in antigen processing and presentation.
• The identification of the genetic locus provides a valuable tool for studying human immune responses and related disorders.